[go: up one dir, main page]

ATE237680T1 - Transplantation von hämatopoietischen zellen - Google Patents

Transplantation von hämatopoietischen zellen

Info

Publication number
ATE237680T1
ATE237680T1 AT00905194T AT00905194T ATE237680T1 AT E237680 T1 ATE237680 T1 AT E237680T1 AT 00905194 T AT00905194 T AT 00905194T AT 00905194 T AT00905194 T AT 00905194T AT E237680 T1 ATE237680 T1 AT E237680T1
Authority
AT
Austria
Prior art keywords
transplantation
hematopoietic cells
disease
treatment
stem cells
Prior art date
Application number
AT00905194T
Other languages
English (en)
Inventor
Jack Price
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Application granted granted Critical
Publication of ATE237680T1 publication Critical patent/ATE237680T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00905194T 1999-02-24 2000-02-23 Transplantation von hämatopoietischen zellen ATE237680T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904281.4A GB9904281D0 (en) 1999-02-24 1999-02-24 Transplantation
PCT/GB2000/000636 WO2000050568A2 (en) 1999-02-24 2000-02-23 Transplantation of haematopoietic cells

Publications (1)

Publication Number Publication Date
ATE237680T1 true ATE237680T1 (de) 2003-05-15

Family

ID=10848438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905194T ATE237680T1 (de) 1999-02-24 2000-02-23 Transplantation von hämatopoietischen zellen

Country Status (20)

Country Link
EP (1) EP1161521B1 (de)
JP (1) JP4716575B2 (de)
KR (1) KR20020000216A (de)
CN (1) CN1636053A (de)
AT (1) ATE237680T1 (de)
AU (1) AU762763B2 (de)
CA (1) CA2361401A1 (de)
CZ (1) CZ20012651A3 (de)
DE (1) DE60002185T2 (de)
DK (1) DK1161521T3 (de)
ES (1) ES2193938T3 (de)
GB (1) GB9904281D0 (de)
HK (1) HK1041284B (de)
HU (1) HUP0105168A3 (de)
NO (1) NO20014091L (de)
PL (1) PL350297A1 (de)
PT (1) PT1161521E (de)
RU (1) RU2216336C2 (de)
SK (1) SK11232001A3 (de)
WO (1) WO2000050568A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
EP1183035B1 (de) * 1999-05-14 2014-12-03 Henry Ford Health System Knochenmarkstransplantation zur behandlung von schlaganfall
WO2003059276A2 (en) * 2002-01-14 2003-07-24 The Board Of Trustees Of The University Of Illinois Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
US20060051860A1 (en) * 2002-11-15 2006-03-09 Kyushu Tlo Company, Limited Method of organ regeneration
DE602005002430T2 (de) 2004-09-30 2008-06-19 Reneuron Ltd., Guildford Zelllinie
RU2283119C1 (ru) * 2005-03-29 2006-09-10 Андрей Степанович БРЮХОВЕЦКИЙ Препарат аутологичных гемопоэтических стволовых клеток, способ его получения, криоконсервации и использования для лечения травматической болезни центральной нервной системы
US7569545B2 (en) * 2005-05-20 2009-08-04 Academia Sinica Methods of increasing neurotrophic factor expression
JP5247675B2 (ja) 2006-03-24 2013-07-24 チルドレンズ メディカル センター コーポレーション 造血性幹細胞の増殖を調節する方法
MX2009004164A (es) 2006-10-20 2009-10-13 Childrens Medical Center Metodo para aumentar la regeneracion de tejido.
JP5555922B2 (ja) 2008-09-16 2014-07-23 ユニバーシティ オブ セントラル フロリダ リサーチ ファウンデーション，インコーポレイテッド 脱毛を治療する、又は、脱毛の発症を遅らせるための組成物
WO2010096264A2 (en) 2009-02-03 2010-08-26 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
US9051548B2 (en) 2009-02-03 2015-06-09 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
EP2699247B1 (de) * 2011-04-20 2018-03-07 The Regents of The University of California Verfahren zur kombinierten konditionierung und chemoselektion in einem einzigen zyklus
EP3381456A1 (de) 2011-12-02 2018-10-03 Fate Therapeutics, Inc. Verbesserte verfahren zur behandlung von ischämie
CN104066837B (zh) 2011-12-02 2020-12-08 菲特治疗公司 增强的干细胞组合物
US10851412B2 (en) 2013-03-15 2020-12-01 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
RU2647429C1 (ru) * 2017-02-06 2018-03-15 Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) Биомедицинский клеточный препарат
RU2720002C1 (ru) * 2018-12-28 2020-04-23 Андрей Степанович БРЮХОВЕЦКИЙ Биомедицинский клеточный продукт для лечения нервных болезней и психических расстройств, способ его получения и его применение
CN114934072B (zh) * 2022-05-18 2023-10-20 华中科技大学同济医学院附属协和医院 一种人心脏瓣膜间质细胞系的永生化构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
WO1993018137A1 (en) * 1992-03-04 1993-09-16 Systemix, Inc. Culturing of hematopoietic stem cells and their genetic engineering
CZ288337B6 (en) * 1995-06-27 2001-05-16 Boehringer Ingelheim Kg Pharmaceutical preparation
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
CA2262817A1 (en) * 1996-08-19 1998-02-26 James Robl Embryonic or stem-like cell lines produced by cross species nuclear transplantation

Also Published As

Publication number Publication date
WO2000050568A3 (en) 2000-12-07
GB9904281D0 (en) 1999-04-21
EP1161521B1 (de) 2003-04-16
HK1041284A1 (en) 2002-07-05
NO20014091D0 (no) 2001-08-23
KR20020000216A (ko) 2002-01-05
AU2682100A (en) 2000-09-14
PT1161521E (pt) 2003-08-29
CN1636053A (zh) 2005-07-06
AU762763B2 (en) 2003-07-03
HK1041284B (zh) 2003-10-03
NO20014091L (no) 2001-08-23
DE60002185T2 (de) 2003-12-18
DE60002185D1 (de) 2003-05-22
JP4716575B2 (ja) 2011-07-06
ES2193938T3 (es) 2003-11-16
CZ20012651A3 (cs) 2002-01-16
CA2361401A1 (en) 2000-08-31
DK1161521T3 (da) 2003-06-16
SK11232001A3 (sk) 2002-01-07
WO2000050568A2 (en) 2000-08-31
RU2216336C2 (ru) 2003-11-20
EP1161521A2 (de) 2001-12-12
PL350297A1 (en) 2002-12-02
HUP0105168A3 (en) 2003-12-29
HUP0105168A2 (hu) 2002-05-29
JP2002537406A (ja) 2002-11-05

Similar Documents

Publication Publication Date Title
ATE237680T1 (de) Transplantation von hämatopoietischen zellen
DE60231708D1 (de) Somatische pluripotente Zellen
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
GB0400167D0 (en) Dopaminergic neurons and proliferation-competent orecursor cells for treating parkinson's disease
GT199600026A (es) Isotiazolonas
SE9900100D0 (sv) New compounds
YU401A (sh) Sredstva sa antidepresivnim dejstvom
LU92433I2 (fr) Olodatérol, ses isomères optiques individuels, mélanges d'énantiomères individuels ou de racémates, ses sels d'addition d'acide avec des acides pharmaceutiquement acceptables, ainsi que ses solvates et/ou ses hydrates, en particulier l'olodatérol et le chlorhydrate d'olodatérol
ATE333849T1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
BR0014169A (pt) Lentes de adição progressiva
DE59603216D1 (de) Esterquats und ihre Verwendung zur Herstellung von oberflächenaktiven Mitteln, insbesondere zur Haar- und Körperpflege
WO2003105725A3 (en) ARTIFICIAL CORNEA
GB2407821A (en) Generation of neural stem cells from undifferentiated human embryonic stem cells
AU2003220096A1 (en) Methods for alzheimer's disease treatment and cognitive enhancement
WO2003039454A8 (en) Beta-secretase inhibitors and methods of use
WO2003102016A3 (en) Amyloid peptide inactivating enzyme to treat alzheimer's disease
WO1998013488A3 (en) Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease
PT983272E (pt) Nova classe de compostos fotoactivos derivados de benzoporfirina
DE60043888D1 (de) Oberfläche für zellkultur
DE50010234D1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
CA95616S (en) Tanned hide
DE69740081D1 (de) Kugelanordnungssubstrat zur herstellung von höckern, kugelanordnungskopf, kugelanordnungsvorrichtung und kugelanordnungsverfahren
RU2002116475A (ru) Способ лечения паркинсонизма и болезни паркинсона
AU307303S (en) Ride on zebra
SE9704458D0 (sv) Anläggning samt förfarande vid en sådan, del 2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1161521

Country of ref document: EP

REN Ceased due to non-payment of the annual fee